Baheal Pharma Group Tech Stack

Pharmaceutical innovator with industrialization platform and medical device manufacturing

Pharmaceutical Manufacturing Beijing, China 1,001–5,000 employees Founded 2005 Public Company

Baheal Pharma Group operates as both a pharma investor and manufacturer, with a dual-track model: incubating early-stage innovations through venture capital and operating a listed manufacturing platform (Baheal Medical, stock code 301015) to commercialize approved products. The tech stack — dominated by industrial automation (Siemens, Rockwell, EtherCAT, PLC) rather than biotech software — reflects a capital-intensive manufacturing operation focused on mass production yield and regulatory compliance, not computational biology.

Tech Stack 19 technologies

Core StackSiemens C++ Python C# AutoCAD Solidworks EPLAN PLC Rockwell Automation Beckhoff Ethernet/IP EtherCAT AutoCAD Electrical C WPF Qt FPGA Pro/ENGINEER Xiaohongshu

What Baheal Pharma Group Is Building

◆Challenges

Production process quality issues
Reducing defect rate
Obtaining government support
Cost reduction for mass production
Meeting emc and safety regulations
Production and hospital site issues
Acquiring government approvals
Deviation investigations
Freedom to operate analysis
Efficient ip management

▲Active Projects

Mass production design optimization and cost reduction
Investment and capital operation projects
Visit system management
Prototype production and test plan
Product design verification
Tooling design and improvement
Project transfer to production
New product development
Patent application and risk warning system
Patent portfolio development

Hiring Activity

Decelerating50 roles · 7 in 30d

Department

Engineering

Sales

Research

Manufacturing

Legal

Finance

Government

Seniority

Mid

Junior

Manager

Senior

Company intelligence

Find more companies like Baheal Pharma Group by tech stack, pain points and active projects

Get started free

About Baheal Pharma Group

Baheal Pharma Group is a public pharmaceutical company (founded 2005, headquartered in Beijing) operating across three value tracks: innovative medicines, high-end medical devices, and basic research platforms. The group functions as both an industry investor—providing funding and technology support to early-stage medical innovators—and a manufacturer through its publicly listed subsidiary Baheal Medical (stock code 301015), which handles product development, manufacturing, and commercialization. The organization spans 1,001–5,000 employees across engineering, sales, research, and manufacturing departments, with active operations in China and South Korea. Current focus areas include mass production design optimization, prototype validation, regulatory approval navigation, and intellectual property portfolio management.

HeadquartersBeijing, China

Company Size1,001–5,000 employees

Founded2005

Hiring MarketsChina, South Korea

Frequently Asked Questions

What manufacturing technologies does Baheal Pharma use?

Baheal's stack centers on industrial automation: Siemens, Rockwell Automation, Beckhoff, EtherCAT, and EtherNet/IP for process control, plus CAD tools (AutoCAD, Solidworks, Pro/ENGINEER) for design and FPGA for embedded systems. Programming languages include C++, C, Python, and C#.

What is Baheal Pharma currently working on?

Top priorities include mass production design optimization and cost reduction, prototype production and test planning, product design verification, new product development, tooling design, and patent portfolio development. Pain points center on production process quality, defect reduction, regulatory compliance (EMC, safety), and government approvals.